Search

Now showing items 1-3 of 3

Specific psychiatric disorders can be identified using systematic assessment in patients with KCNJ11 neonatal diabetes

Bowman, P.; Broadbridge, E.; Knight, Bridget A.; Pettit, L.; Flanagan, Sarah; Reville, M.; Tonks, J.; Shepherd, Maggie; Ford, T. J.; Hattersley, Andrew T. (Wiley, 2016-03)
Evaluating the Exeter Glucose Potentiated Arginine Insulin Secretion (E-GPAIS) test for recruit by genotype studies

Pitt, Andrew; Knight, Bridget A.; Hudson, M.; Beall, Lynsey; Hattersley, Andrew T.; Jones, Angus G.; Frayling, T. M. (Wiley, 2016-03)
Patterns of postmeal insulin secretion in individuals with sulfonylurea- treated KCNJ11 neonatal diabetes show predominance of non- KATP- channel pathways

Bowman, Pamela; McDonald, Timothy J.; Knight, Bridget A.; Flanagan, Sarah; Leveridge, Maria; Spaull, Steve R; Shields, Beverley M; Hammersley, Suzanne; Shepherd, Maggie; Andrews, Rob; Patel, Kashyap A; Hattersley, Andrew T. (BMJ, 2019-12)
Insulin secretion in sulfonylurea-treated KCNJ11 permanent neonatal diabetes mellitus (PNDM) is thought to be mediated predominantly through amplifying non-KATP-channel pathways such as incretins. Affected individuals ...